Abbott Hit With $1.7B Verdict In IP Suit Over Humira

Law360, New York (June 30, 2009, 12:00 AM EDT) -- A jury in the U.S. District Court for the Eastern District of Texas has hit Abbott Laboratories with possibly the largest patent verdict in U.S. history, awarding Johnson & Johnson subsidiary Centocor Inc. $1.67 billion and finding that Abbott's flagship arthritis drug Humira infringed a Centocor patent.

After a weeklong trial, the jury on Monday ruled that Centocor's patent, which is co-owned with New York University, was valid and Abbott's infringement was willful. It awarded Centocor $1.17 billion in lost profits and $504 million in royalties....
To view the full article, register now.